Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review.

The optimal cumulative dose and timing of cisplatin administration in various concurrent chemoradiotherapy protocols for nonmetastatic head and neck squamous cell carcinoma (HNSCC) has not been determined.